HEADER    TOXIN                                   02-AUG-05   2AK0              
TITLE     STRUCTURE OF CYCLIC CONOTOXIN MII-7                                   
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: ALPHA-CONOTOXIN MII;                                       
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: CYCLIC MII-7, M2;                                           
COMPND   5 ENGINEERED: YES;                                                     
COMPND   6 OTHER_DETAILS: GAGGAAG IS USED AS A LINKER TO CYCLISE THE PEPTIDE    
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 OTHER_DETAILS: A LINEAR PEPTIDE OCCURS NATURALLY IN CONE SNAILS      
KEYWDS    ALPHA-HELIX, CYCLIC BACKBONE, TOXIN                                   
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    R.J.CLARK,H.FISCHER,L.DEMPSTER,N.L.DALY,K.J.ROSENGREN,S.T.NEVIN,      
AUTHOR   2 F.A.MEUNIER,D.J.ADAMS,D.J.CRAIK                                      
REVDAT   5   30-OCT-24 2AK0    1       REMARK                                   
REVDAT   4   09-MAR-22 2AK0    1       REMARK SEQADV                            
REVDAT   3   24-FEB-09 2AK0    1       VERSN                                    
REVDAT   2   01-NOV-05 2AK0    1       JRNL                                     
REVDAT   1   06-SEP-05 2AK0    0                                                
JRNL        AUTH   R.J.CLARK,H.FISCHER,L.DEMPSTER,N.L.DALY,K.J.ROSENGREN,       
JRNL        AUTH 2 S.T.NEVIN,F.A.MEUNIER,D.J.ADAMS,D.J.CRAIK                    
JRNL        TITL   ENGINEERING STABLE PEPTIDE TOXINS BY MEANS OF BACKBONE       
JRNL        TITL 2 CYCLIZATION: STABILIZATION OF THE {ALPHA}-CONOTOXIN MII.     
JRNL        REF    PROC.NATL.ACAD.SCI.USA        V. 102 13767 2005              
JRNL        REFN                   ISSN 0027-8424                               
JRNL        PMID   16162671                                                     
JRNL        DOI    10.1073/PNAS.0504613102                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : XWINNMR 1.3.5, CNS 1.1                               
REMARK   3   AUTHORS     : BRUKER (XWINNMR),                                    
REMARK   3  BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI,   
REMARK   3  NILGES, PANNU,READ,RICE,SIMONSON,WARREN (CNS)                       
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2AK0 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 04-AUG-05.                  
REMARK 100 THE DEPOSITION ID IS D_1000033985.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 298                                
REMARK 210  PH                             : 3.5                                
REMARK 210  IONIC STRENGTH                 : NULL                               
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 1MM CYCLIC MII-7                   
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D NOESY; 2D TOCSY; DQF-COSY; E    
REMARK 210                                   -COSY                              
REMARK 210  SPECTROMETER FIELD STRENGTH    : 500 MHZ; 600 MHZ; 750 MHZ          
REMARK 210  SPECTROMETER MODEL             : AVANCE; DMX                        
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : XEASY 1.3.7, DYANA 1.5, CNS 1.1    
REMARK 210   METHOD USED                   : SIMULATED ANNEALING                
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 50                                 
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: CLOSE CONTACTS                                             
REMARK 500                                                                      
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
REMARK 500                                                                      
REMARK 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
REMARK 500   N    GLY A     1     C    GLY A    23              1.33            
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 HIS A  12       40.98    -89.64                                   
REMARK 500  2 HIS A  12       42.34    -93.92                                   
REMARK 500  2 ALA A  18       42.00    -87.34                                   
REMARK 500  3 HIS A  12       46.51   -107.92                                   
REMARK 500  3 CYS A  16       36.87    -78.88                                   
REMARK 500  3 ALA A  18      115.66   -170.71                                   
REMARK 500  3 ALA A  21       42.82    -78.89                                   
REMARK 500  4 HIS A  12       40.62    -97.21                                   
REMARK 500  4 ALA A  21       38.33    -82.18                                   
REMARK 500  4 ALA A  22      132.49   -174.67                                   
REMARK 500  5 CYS A  16       38.36    -92.12                                   
REMARK 500  6 HIS A  12       43.43    -97.32                                   
REMARK 500  6 CYS A  16       46.28    -83.06                                   
REMARK 500  6 ALA A  22     -152.38     60.96                                   
REMARK 500  7 HIS A  12       41.37    -93.58                                   
REMARK 500  8 HIS A  12       35.02    -92.68                                   
REMARK 500  9 HIS A  12       43.58    -91.65                                   
REMARK 500  9 CYS A  16       38.67    -89.97                                   
REMARK 500 10 HIS A  12       50.37   -100.34                                   
REMARK 500 10 ALA A  18       57.47   -105.92                                   
REMARK 500 10 ALA A  21       74.62   -150.82                                   
REMARK 500 11 HIS A  12       38.69    -90.56                                   
REMARK 500 11 CYS A  16       47.14   -101.34                                   
REMARK 500 12 HIS A  12       41.02   -103.64                                   
REMARK 500 12 ALA A  18       47.14    -98.06                                   
REMARK 500 13 HIS A  12       38.22    -92.48                                   
REMARK 500 13 ALA A  21      139.95   -172.34                                   
REMARK 500 13 ALA A  22      149.77     67.55                                   
REMARK 500 14 CYS A  16       33.86    -87.09                                   
REMARK 500 14 ALA A  18       41.34   -156.19                                   
REMARK 500 15 HIS A  12       43.46    -91.57                                   
REMARK 500 15 CYS A  16       41.87    -93.29                                   
REMARK 500 16 ALA A  21      144.09   -178.54                                   
REMARK 500 16 ALA A  22     -151.96     57.45                                   
REMARK 500 17 HIS A  12       44.46    -91.34                                   
REMARK 500 17 CYS A  16       36.60    -82.42                                   
REMARK 500 17 ALA A  18       41.32   -153.25                                   
REMARK 500 18 HIS A  12       47.99    -92.20                                   
REMARK 500 18 CYS A  16       38.87    -89.96                                   
REMARK 500 18 ALA A  21     -147.00   -165.82                                   
REMARK 500 18 ALA A  22     -158.08     63.40                                   
REMARK 500 19 HIS A  12       43.26    -98.08                                   
REMARK 500 19 CYS A  16       42.38    -83.13                                   
REMARK 500 20 HIS A  12       39.01    -89.52                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 2AJW   RELATED DB: PDB                                   
REMARK 900 THE SAME "PARENT" PEPTIDE CYCLIZED WITH A DIFFERENT SIZE LINKER      
REMARK 900 (GGAAGG)                                                             
DBREF  2AK0 A    1    16  UNP    P56636   CXA2_CONMA      22     37             
SEQADV 2AK0 GLY A   17  UNP  P56636              LINKER                         
SEQADV 2AK0 ALA A   18  UNP  P56636              LINKER                         
SEQADV 2AK0 GLY A   19  UNP  P56636              LINKER                         
SEQADV 2AK0 GLY A   20  UNP  P56636              LINKER                         
SEQADV 2AK0 ALA A   21  UNP  P56636              LINKER                         
SEQADV 2AK0 ALA A   22  UNP  P56636              LINKER                         
SEQADV 2AK0 GLY A   23  UNP  P56636              LINKER                         
SEQRES   1 A   23  GLY CYS CYS SER ASN PRO VAL CYS HIS LEU GLU HIS SER          
SEQRES   2 A   23  ASN LEU CYS GLY ALA GLY GLY ALA ALA GLY                      
HELIX    1   1 ASN A    5  HIS A   12  1                                   8    
HELIX    2   2 HIS A   12  GLY A   17  1                                   6    
SSBOND   1 CYS A    2    CYS A    8                          1555   1555  2.03  
SSBOND   2 CYS A    3    CYS A   16                          1555   1555  2.03  
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
MODEL        1